FDA approves Arcapta

FDA approved 75 ug once-daily Arcapta Neohaler indacaterol from Novartis AG (NYSE:NVS; SIX:NOVN) for the maintenance treatment of

Read the full 189 word article

How to gain access

Continue reading with a
two-week free trial.